ArticleCell reports2026
Outer membrane remodeling via lipid-peptidoglycan crosstalk enables lipooligosaccharide-deficient colistin resistance.
Article in Cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Peptidoglycan Remodeling in Gram-Negative Bacteria: From Stress Adaptation to Antibiotic Tolerance and Therapeutic Targeting.Antibiotics (Basel, Switzerland) · 2026Review
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Gram-negative bacteria rely on an asymmetric outer membrane for barrier integrity, with phospholipids confined to the inner leaflet and lipopolysaccharide or lipooligosaccharide (LOS) forming the outer leaflet. Although these glycolipids were long considered essential, recent findings challenge this view. Here, using Acinetobacter baumannii, we identify lipid asymmetry as a structural checkpoint controlling access to LOS-independent survival. Disruption of phospholipid transport and degradation destabilizes membrane balance, creating a permissive state that enables the emergence of LOS-deficient, colistin-resistant variants. Lipidomic and transcriptomic analyses reveal coordinated envelope remodeling, including altered peptidoglycan synthesis and enhanced envelope trafficking. Loss of LOS coincides with repression of PBP1A, and maintaining its activity blocks adaptation. We propose a three-state model-basal, permissive, and adapted-that explains how envelope architecture governs antibiotic resistance and membrane remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.